Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
22/01/2024 12:03
Jan 22 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* NGM BIOPHARMACEUTICALS- ON JAN 18, GOT WRITTEN NOTICE FROM
NASDAQ INFORMING CO IT HAS REGAINED COMPLIANCE WITH NASDAQ
LISTING RULE 5450(A)(1)
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors